|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/28 | (2006.01) |
| A61K 31/155 | (2013.01) | ||
| A61K 31/155 | (2006.01) | ||
| A61K 38/28 | (2013.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61K 9/0019 | (2013.01) | ||
| A61K 38/26 | (2013.01) | ||
| A61P 3/04 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 3/10 | (2018.01) |
| (11) | Number of the document | 3268029 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16711171.5 |
| Date of filing the European patent application | 2016-03-11 | |
| (97) | Date of publication of the European application | 2018-01-17 |
| (45) | Date of publication and mention of the grant of the patent | 2022-04-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2016/055267 |
| Date | 2016-03-11 |
| (87) | Number | WO 2016/146514 |
| Date | 2016-09-22 |
| (30) | Number | Date | Country code |
| 15159064 | 2015-03-13 | EP |
| (72) |
ROY, Christine , FR
SOUHAMI, Elisabeth , FR
DEMIL, Nacima , FR
YE, Jenny , US
|
| (73) |
Sanofi-Aventis Deutschland GmbH ,
Brüningstraße 50, 65929 Frankfurt,
DE
|
| (54) | TREATMENT OF TYPE 2 DIABETES MELLITUS PATIENTS |
| TREATMENT OF TYPE 2 DIABETES MELLITUS PATIENTS |